BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
CLSA upgrades Ipca Laboratories to buy
CLSA upgraded Ipca Laboratories to "buy" from "sell" earlier with a target price of Rs 500. India business of the company will grow going ahead. International business of the company to recover gradually. Risk reward is favourable at current price.